rs876659149
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_000051.4(ATM):c.2115C>G(p.Tyr705*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_000051.4 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ATM | NM_000051.4 | c.2115C>G | p.Tyr705* | stop_gained | Exon 13 of 63 | ENST00000675843.1 | NP_000042.3 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 30
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Ataxia-telangiectasia syndrome Pathogenic:1
This premature translational stop signal has been observed in individual(s) with ataxia-telangiectasia (PMID: 29492593). This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Tyr705*) in the ATM gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ATM are known to be pathogenic (PMID: 23807571, 25614872). ClinVar contains an entry for this variant (Variation ID: 389328). For these reasons, this variant has been classified as Pathogenic. -
not provided Pathogenic:1
This variant is denoted ATM c.2115C>G at the cDNA level and p.Tyr705Ter (Y705X) at the protein level. The substitution creates a nonsense variant, which changes a Tyrosine to a premature stop codon (TAC>TAG), and is predicted to cause loss of normal protein function through either protein truncation or nonsense-mediated mRNA decay. Although this variant has not, to our knowledge, been reported in the literature, it is considered to be a likely pathogenic variant. -
Hereditary cancer-predisposing syndrome Pathogenic:1
The p.Y705* pathogenic mutation (also known as c.2115C>G), located in coding exon 12 of the ATM gene, results from a C to G substitution at nucleotide position 2115. This changes the amino acid from a tyrosine to a stop codon within coding exon 12. This mutation was reported in trans with a missense ATM alteration of unknown significance in an individual with a clinical diagnosis of ataxia-telangiectasia and trisomy X (Sharapova SO et al. Immunogenetics, 2018 Sep;70(9):613-617). This variant is considered to be rare based on population cohorts in the Genome Aggregation Database (gnomAD). In addition to the clinical data presented in the literature, this alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. -
Familial cancer of breast Pathogenic:1
This variant is considered pathogenic. This variant creates a termination codon and is predicted to result in premature protein truncation. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at